$132B
$59.3 Million
0.23% of portfolio
789,244
Q3 2024
Added 409.86%
$1.05T
$44.3 Million
0.18% of portfolio
255,019
Q3 2024
Reduced 18.86%
$236B
$42.8 Million
0.17% of portfolio
157,659
Q3 2024
Reduced 22.67%
$206B
$39.4 Million
0.16% of portfolio
409,380
Q3 2024
Added 3.33%
$308B
$37.4 Million
0.15% of portfolio
308,020
Q3 2024
Added 0.52%
$42.4B
$38.4 Million
0.15% of portfolio
537,812
Q3 2024
Added 147.79%
$435B
$34.9 Million
0.14% of portfolio
49,212
Q3 2024
Added 2.5%
$20.8B
$32.8 Million
0.13% of portfolio
165,245
Q3 2024
Added 82.48%
$13.6B
$32.2 Million
0.13% of portfolio
614,104
Q3 2024
Added 32.85%
$205B
$32 Million
0.13% of portfolio
61,827
Q3 2024
Reduced 43.57%
$74.7B
$28 Million
0.11% of portfolio
270,175
Q3 2024
Reduced 9.48%
$423B
$28.8 Million
0.11% of portfolio
71,127
Q3 2024
Reduced 13.94%
$256B
$26.6 Million
0.11% of portfolio
250,243
Q3 2024
Added 2.04%
$129B
$28.1 Million
0.11% of portfolio
267,324
Q3 2024
Reduced 6.95%
$167B
$26.6 Million
0.11% of portfolio
42,812
Q3 2024
Reduced 20.55%
$9.96B
$25.4 Million
0.1% of portfolio
671,495
Q3 2024
Reduced 0.07%
$153B
$23 Million
0.09% of portfolio
93,341
Q3 2024
Added 32.43%
$125B
$22.9 Million
0.09% of portfolio
82,692
Q3 2024
Reduced 0.16%
$95.1B
$21 Million
0.08% of portfolio
10,228
Q3 2024
Reduced 5.45%
$144B
$17.3 Million
0.07% of portfolio
147,059
Q3 2024
Reduced 5.56%
$58.1B
$18 Million
0.07% of portfolio
429,849
Q3 2024
Reduced 12.0%
$78.4B
$16.4 Million
0.07% of portfolio
34,958
Q3 2024
Added 13.4%
$25.9B
$16 Million
0.06% of portfolio
152,962
Q3 2024
Reduced 37.87%
$78.3B
$14.1 Million
0.06% of portfolio
191,984
Q3 2024
Reduced 27.83%
$52.1B
$13.6 Million
0.05% of portfolio
90,227
Q3 2024
Reduced 6.31%
$80.9B
$12.7 Million
0.05% of portfolio
11,058
Q3 2024
Reduced 53.42%
$19.1B
$9.65 Million
0.04% of portfolio
96,803
Q3 2024
Added 40.57%
$169B
$11.3 Million
0.04% of portfolio
251,218
Q3 2024
Reduced 5.85%
$12.7B
$8.94 Million
0.04% of portfolio
20,437
Q3 2024
Added 297.45%
$32.6B
$8.79 Million
0.03% of portfolio
61,303
Q3 2024
Reduced 1.69%
$131B
$8.42 Million
0.03% of portfolio
55,000
Q3 2024
New
$44.7B
$8.53 Million
0.03% of portfolio
625,000
Q3 2024
Reduced 3.85%
$99.8B
$3.88 Million
0.02% of portfolio
130,000
Q3 2024
Added 4.0%
$34.9B
$4.32 Million
0.02% of portfolio
8,545
Q3 2024
Added 156.61%
$79.5B
$3.95 Million
0.02% of portfolio
14,580
Q3 2024
Added 20.61%
$36.6B
$3.93 Million
0.02% of portfolio
160,000
Q3 2024
Added 14.29%
$423B
$2.07 Million
0.01% of portfolio
3
Q1 2024
Reduced 25.0%
$8.24B
$2.89 Million
0.01% of portfolio
11,300
Q2 2024
Added 30.64%
$52.9B
$3.55 Million
0.01% of portfolio
27,960
Q3 2024
Added 50.1%
$30.8B
$2.32 Million
0.01% of portfolio
30,731
Q3 2024
Added 4.66%
$19B
$3.6 Million
0.01% of portfolio
80,000
Q3 2024
Reduced 11.11%
$31B
$2.12 Million
0.01% of portfolio
21,500
Q3 2024
Added 22.86%
$66.3B
$2.1 Million
0.01% of portfolio
22,500
Q3 2024
Reduced 10.0%
$8.69B
$3.27 Million
0.01% of portfolio
16,500
Q3 2024
Added 10.0%
$5.65B
$1.51 Million
0.01% of portfolio
17,500
Q3 2024
Reduced 20.45%
$10.6B
$1.11 Million
0.0% of portfolio
6,000
Q3 2024
Reduced 7.69%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 14.94%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 41.51%
0,250 Halozyme Therapeutics 01.03.2027
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 19.15%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 56.52%